{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T01:40:59Z","timestamp":1788054059278,"version":"build-2784847793"},"reference-count":35,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T00:00:00Z","timestamp":1490227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Sato Pharmaceutical, Japan"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Onychomycosis is a highly prevalent and intractable disease. The first\u2010line treatment agents are oral preparations, but an effective topical medication has long been desired. The objective was to investigate the efficacy and safety of luliconazole 5% nail solution, an imidazole antifungal agent, for the treatment of patients with onychomycosis. A multicenter, double\u2010blind, randomized phase\n                    <jats:styled-content style=\"fixed-case\">III<\/jats:styled-content>\n                    study was conducted in Japanese patients with distal lateral subungual onychomycosis affecting the great toenails, with 20\u201350% clinical involvement. Patients were randomized (2:1) to luliconazole or vehicle once daily for 48 weeks. The primary end\u2010point was the complete cure rate (clinical cure [0% clinical involvement of the nail] plus mycological cure [negative results on direct microscopy]). The adverse event incidence was monitored to evaluate safety. The complete cure rate significantly favored luliconazole (14.9%, 29\/194 subjects) versus vehicle (5.1%, 5\/99) (\n                    <jats:italic>P<\/jats:italic>\n                    = 0.012). Similarly, the negative direct microscopy rate was significantly higher with luliconazole (45.4%, 79\/174) than with vehicle (31.2%, 29\/93) (\n                    <jats:italic>P<\/jats:italic>\n                    = 0.026). There were no serious adverse drug reactions. We conclude that once daily topical luliconazole 5% nail solution demonstrated clinical efficacy and was confirmed to be well tolerated.\n                  <\/jats:p>","DOI":"10.1111\/1346-8138.13816","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T02:22:38Z","timestamp":1490322158000},"page":"753-759","source":"Crossref","is-referenced-by-count":48,"title":["Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: A multicenter, double\u2010blind, randomized phase\n                    <scp>III<\/scp>\n                    study"],"prefix":"10.1111","volume":"44","author":[{"given":"Shinichi","family":"Watanabe","sequence":"first","affiliation":[{"name":"Department of Dermatology Teikyo University School of Medicine Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kishida","sequence":"additional","affiliation":[{"name":"Sato Pharmaceutical Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Okubo","sequence":"additional","affiliation":[{"name":"Sato Pharmaceutical Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,3,23]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"90","article-title":"LUZU (luliconazole) 1% cream","volume":"12","author":"Gupta AK","year":"2014","journal-title":"Skinmed"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-004-0327-1"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-006-0440-4"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/13693780802541518"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.3314\/mmj.57.J1"},{"key":"e_1_2_7_7_1","unstructured":"LUZU [package insert].Bridgewater NJ:Medicis a division of Valeant Pharmaceuticals 2013."},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.2147\/CE.S49629"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.107754"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.3314\/jjmm.44.253"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1999.00015.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20142569"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2009.04025.x"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13358"},{"key":"e_1_2_7_15_1","first-page":"1173","article-title":"Therapeutic update: onychomycosis","volume":"13","author":"Rose AE","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000018488"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1800"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2010.07.008"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1997.03890450124022"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543780902810352"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.3314\/mmj.57.J19"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.3314\/mmj.57.J13"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.10.013"},{"key":"e_1_2_7_24_1","unstructured":"SPORANOX\u00ae(itraconazole) [package insert].Titusville NJ:Janssen Pharmaceuticals Inc. 2015."},{"key":"e_1_2_7_25_1","first-page":"217","article-title":"Double\u2010blind, randomized comparison of itraconazole capsules vs. placebo in the treatment of toenail onychomycosis","volume":"59","author":"Elewski BE","year":"1997","journal-title":"Cutis"},{"key":"e_1_2_7_26_1","unstructured":"LAMISIL\u00ae(terbinafine) [package insert].East Hanover NJ:Novartis Pharmaceuticals Corporation 2013."},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.04.010"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200405030-00002"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03487.x"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/geronj\/10.4.401"},{"key":"e_1_2_7_31_1","first-page":"99","article-title":"Nail growth","volume":"39","author":"Dawber R","year":"1987","journal-title":"Cutis"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.jfas.2008.12.012"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03545.x"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05381.x"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2001.00044.x"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02706-13"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1346-8138.13816","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1346-8138.13816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T12:36:46Z","timestamp":1695559006000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1346-8138.13816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,23]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1111\/1346-8138.13816"],"URL":"https:\/\/doi.org\/10.1111\/1346-8138.13816","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727450109.793561576","asserted-by":"object"}]},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,23]]}}}